The global
CMF (Craniomaxillofacial) Devices Market estimated at $2.2
billion (2022), is growing at a CAGR of 6.8%. The
craniomaxillofacial devices market growth is driven by an increasing volumes of
CMF procedures and the growing adoption of patient specific implants.
CMF devices are used during surgeries to treat injuries,
defects, and diseases in the head, neck, face, jaws, hard and soft tissues of
the cranial and maxillofacial region. The CMF devices market consists of
implants, software, anatomic models, instruments, and surgical guides.
Download a free sample report now 👉
https://meditechinsights.com/cmf-craniomaxillofacial-devices-market/request-sample/
High incidence of traumatic brain injuries (TBIs) is
driving the demand for CMF devices
Head injuries are one of the most common causes of
disability and death in adults. According to the Journal of Neurosurgery, 69
million individuals across the globe are estimated to sustain a TBI each year.
About 2.8 million TBIs occur in the U.S. every year (Source: CDC). Large number
of TBIs and associated skull fractures are driving the demand for CMF devices.
Sports related injuries are propelling the volumes of CMF
procedures
The growth in the number of injuries caused due to sports
activities is expected to increase the demand for CMF devices. According to
John Hopkins Medicine, over 3.5 million sports-related injuries are reported
every year in the U.S and almost one-third of all injuries incurred in
childhood are sports-related injuries.
Growing demand for patient specific implants (PSIs)
The CMF devices market is dominated by
standard/off-the-shelf implants. However, the demand for patient-specific
implants is growing. This is attributed to the advances in imaging techniques
that allow physicians to recreate a computerized model of the patient's anatomy
and provide personalized solutions. Further, improvements in the CMF planning
software have added tools that help surgeons make almost any measurement
possible and align the bone segments in a perfectly symmetrical manner. This
has enabled designing patient specific solutions with high accuracy.
Point of Care (POC) 3D Printing to offer growth
opportunities in Craniomaxillofacial Devices Market
Point of care (POC) 3D printing is likely to find greater
traction in the coming years. Hospitals are increasingly looking for POC 3D
printing solutions owing to its benefits like direct communication between
engineer and the surgeon and accelerated delivery. Key players such as KLS
Martin have already began to focus on POC services. Recently, Charite hospital
(Germany) entered into a public-private partnership with KLS Martin. They
shared investment for the printers in hospitals and KLS is printing the implants
for Charite.
North America leads the adoption of Craniomaxillofacial
Devices Market
From a geographic perspective, North America has a major
market share of global CMF devices market. This is mainly attributed to the
large volumes of CMF procedures, high incidence of trauma injuries, relatively
greater penetration and reimbursement of CMF products in the region.
Download a sample report for
in-depth competitive insights
https://meditechinsights.com/cmf-craniomaxillofacial-devices-market/request-sample/
Competitive Landscape Analysis: Craniomaxillofacial
Devices Market
Some of the key players operating in the global CMF devices
market include KLS Martin, DePuy Synthes Companies (JnJ), Stryker, Medartis,
Renishaw, Zimmer Biomet, Medtronic, Materialise, Xilloc Medical, Synimed,
Medicon, 3D Systems, 3D Life Prints, Nutechnologies, 3Di, among others.
Companies adopting organic growth strategies to increase
their market share
As a key growth strategy, companies in the
Craniomaxillofacial Devices market are focusing on strategic expansions. For
instance,
- In
2021, KLS Martin opened the new production building "Building
70" in Mühlheim, Germany. In the U.S. the company expanded its
production building. Further, a new, larger office with a showroom was
inaugurated in Shanghai, China.
- In
March 2020, KLS Martin opened a new planning office for Individual Patient
Solutions (IPS) in Cardiff, U.K. to bring a more personal and local
service to UK clinicians.
In January 2019, DePuy Synthes invested €36 million in
expanding R&D capabilities at its Ireland Innovation Center. The investment
would help a five-year project focusing on advancing material science in 3D
printing, coatings and surface treatments for high quality implants and medical
devices. The investment also aimed an establishment of a 3D Printing
Development and Launch Center.
Medi-Tech Insights
is a healthcare-focused business research & insights firm. Our clients
include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have completed 100+ projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices & Pharma Services in the areas of
market assessments, due diligence, competitive intelligence, market sizing and
forecasting, pricing analysis & go-to-market strategy. Our methodology
includes rigorous secondary research combined with deep-dive interviews with
industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment